Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

The use of atypical antipsychotics in pediatric bipolar disorder Teleconference on the Use of Atypical Antipsychotics in Pediatric Psychiatric Disorders Chang, K. D. PHYSICIANS POSTGRADUATE PRESS. 2008: 4–8

Abstract

Diagnosis of bipolar disorder in children and adolescents is increasing, and the early-onset form of bipolar disorder usually carries more morbidity than later-onset forms. Patient education and psychotherapeutic and psychosocial interventions should be used in conjunction with carefully planned medication regimens. Recent data support the use of atypical antipsychotics for manic or mixed states in children and adolescents. However, more information is needed about long-term treatment of mania, treatment of bipolar depression, and treatment of comorbid psychiatric conditions.

View details for Web of Science ID 000256559100001

View details for PubMedID 18533762